Diagnosis–Treatment Discordance in Suspected Lyme Neuroborreliosis: A Retrospective Cohort Study from a Romanian Tertiary Centre (2008–2025)
Pathogens · 2026
DOI: 10.3390/pathogens15101072 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pathogens, 2026. Verfasst von Cristina Alexandra Cheran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania. Hauptthemen laut MEDLINE: Lyme Neuroborreliosis, Anti-Bacterial Agents. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
European and Romanian recommendations for Lyme neuroborreliosis (LNB) emphasise cerebrospinal fluid (CSF) pleocytosis and a positive intrathecal antibody index (IAI) for diagnostic confirmation. We assessed whether antibiotic treatment in suspected LNB aligns with diagnostic recommendations.
Methods
We conducted a retrospective, single-centre cohort study of patients with suspected LNB between 2008 and 2025, all with positive first-tier ELISA (enzyme-linked immunosorbent assay) Borrelia serology. Patients were classified as confirmed, probable, possible, or ruled-out LNB based on clinical presentation, serology, and CSF findings. We assessed factors associated with antibiotic treatment and temporal changes in diagnostic work-up and treatment patterns.
Results
Among 58 patients, LNB was confirmed in 4 (6.9%), probable in 11 (19.0%), possible in 31 (53.4%), and ruled out in 12 (20.7%). Antibiotics were administered to 47 patients (81.0%), of whom 68.1% had possible or ruled out LNB. Antibiotic treatment was more frequent in early-stage than in late-stage disease (38/42, 90.5% vs. 9/16, 56.2%; p = 0.006); no significant association was detected with confirmed (p = 1.000) or ruled-out (p = 0.681) status. Between 2008 and 2019 and 2023–2025, IAI testing increased significantly (35.1% vs. 71.4%, p = 0.013), yet overall antibiotic use remained unchanged (81.1% vs. 81.0%, p = 1.000).
Conclusions
Antibiotic treatment was poorly aligned with diagnostic classification, with most treated patients lacking confirmation. Improved diagnostic evaluation over time was not accompanied by a reduction in antibiotic use, highlighting a critical need for stronger diagnostic and antibiotic stewardship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of Infectious Diseases, Bucharest Emergency University Hospital, 050098 Bucharest, Romania.
- "Prof. Dr. Matei Bals" National Institute of Infectious Diseases, 021105 Bucharest, Romania.
ORCID-Profile: Cristina Alexandra Cheran, Adriana Hristea
Zitieren
APA
Cheran, C. A., Tirlescu, L. G., Panciu, A. M., & Hristea, A. (2026). Diagnosis–Treatment Discordance in Suspected Lyme Neuroborreliosis: A Retrospective Cohort Study from a Romanian Tertiary Centre (2008–2025). Pathogens. https://doi.org/10.3390/pathogens15101072
Vancouver
Cheran CA, Tirlescu LG, Panciu AM, Hristea A. Diagnosis–Treatment Discordance in Suspected Lyme Neuroborreliosis: A Retrospective Cohort Study from a Romanian Tertiary Centre (2008–2025). Pathogens. 2026. doi:10.3390/pathogens15101072
BibTeX
@article{Cheran2026,
author = {Cheran, Cristina Alexandra and Tirlescu, Laura Georgiana and Panciu, Andreea Madalina and Hristea, Adriana},
title = {Diagnosis–Treatment Discordance in Suspected Lyme Neuroborreliosis: A Retrospective Cohort Study from a Romanian Tertiary Centre (2008–2025)},
journal = {Pathogens},
year = {2026},
doi = {10.3390/pathogens15101072}
}
EUVIMED